Polyrocks(SH:688669) Jing Ji Guan Cha Wang·2026-02-04 11:38Core Viewpoint - Guangdong Jushi Chemical Co., Ltd. is facing significant regulatory scrutiny and operational challenges following the revelation of inflated revenues through false trading practices, leading to substantial financial losses and a need for compliance restructuring [1][2][3]. Regulatory Actions - The China Securities Regulatory Commission (CSRC) imposed a fine of 2.4 million yuan on Jushi Chemical for inflating revenue by 156.8 million yuan in the first half of 2023 through three types of transactions lacking commercial substance [2][3]. - Four senior executives were held accountable, with fines ranging from 80,000 to 180,000 yuan for their roles in the violations [2]. Financial Performance - Jushi Chemical anticipates a net loss of 900 million to 1.2 billion yuan for 2025, marking the second consecutive year of significant losses, following a net loss of approximately 236 million yuan in 2024 [1][3]. - The company’s revenue from liquefied petroleum gas (LPG) is expected to decline sharply due to volatile international oil prices, exacerbating operational losses [3][4]. Operational Challenges - Despite divesting from problematic subsidiaries and experiencing some improvements in other segments, the overall financial outlook remains bleak, with non-recurring net losses projected to reach 1.25 billion to 1.55 billion yuan [3][4]. - The company has acknowledged issues with revenue recognition and related party transaction disclosures, indicating a need for comprehensive internal control reforms [4][5]. Market Reaction - Following the announcements, Jushi Chemical's stock price saw a slight increase, closing at 26.50 yuan, but concerns about the company's governance and profitability persist among investors [4][5]. - The market remains cautious, with ongoing doubts about the sustainability of the company's business model and its ability to generate stable cash flows [5][6].